Several circulating molecules have been investigated in the quest for markers of excessive inflammatory response to guide early risk stratification and management in patients with COVID-19, including C-reactive protein, pre-albumin, albumin, lactate dehydrogenase, hydroxybutyrate dehydrogenase, and D-dimer (8, 13–15). Here, ALB is linked to COVID-19.